| Dr Shirley Anne Vanmilder, MD | |
|
1221 Mercantile Lane, Largo, MD 20774 | |
| (301) 618-5679 | |
| (301) 618-5673 |
| Full Name | Dr Shirley Anne Vanmilder |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 1221 Mercantile Lane, Largo, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144360587 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D64875 (Maryland) | Primary |
| 207V00000X | Obstetrics & Gynecology | MD036422 (District Of Columbia) | Secondary |
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
A new study by researchers from Harvard T.H. Chan School of Public Health and colleagues describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.
TeamStaff, Inc. (Nasdaq: TSTF), a national provider of healthcare and administrative staffing services, today announced that on September 15, 2009, it received a notice from the Listing Qualifications Department of The Nasdaq Global Market (Nasdaq) stating that for the last 30 consecutive trading days, the Company's common stock has not maintained a minimum market value of publicly held shares of $5,000,000, as required by the continued listing requirements of the Nasdaq Global Market set forth in Listing Rule 5450(b)(1)(C) (the "Listing Rule").
For most patients, melanoma begins with a small, pigmented spot on their skin that they notice starts to change.
Ramius V&O Acquisition LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today announced that it has sent a letter to the Board of Directors of Cypress Bioscience, Inc. outlining its willingness to acquire all of Cypress' outstanding Common Stock in a negotiated transaction for $5.50 per share. The offer is conditioned upon Cypress commencing exclusive negotiations with Ramius no later than Friday, December 10, 2010 and entering into a definitive merger agreement by no later than Sunday, December 12, 2010.
The WiCell Research Institute (WiCell) and Advanced Cell Technology announced today an agreement, in principle, to collaborate to jointly distribute to U.S. scientists a range of new cell lines.
› Verified 3 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1578638425 PECOS PAC ID: 3779495858 Enrollment ID: O20040805001280 |
News Archive
A new study by researchers from Harvard T.H. Chan School of Public Health and colleagues describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.
TeamStaff, Inc. (Nasdaq: TSTF), a national provider of healthcare and administrative staffing services, today announced that on September 15, 2009, it received a notice from the Listing Qualifications Department of The Nasdaq Global Market (Nasdaq) stating that for the last 30 consecutive trading days, the Company's common stock has not maintained a minimum market value of publicly held shares of $5,000,000, as required by the continued listing requirements of the Nasdaq Global Market set forth in Listing Rule 5450(b)(1)(C) (the "Listing Rule").
For most patients, melanoma begins with a small, pigmented spot on their skin that they notice starts to change.
Ramius V&O Acquisition LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today announced that it has sent a letter to the Board of Directors of Cypress Bioscience, Inc. outlining its willingness to acquire all of Cypress' outstanding Common Stock in a negotiated transaction for $5.50 per share. The offer is conditioned upon Cypress commencing exclusive negotiations with Ramius no later than Friday, December 10, 2010 and entering into a definitive merger agreement by no later than Sunday, December 12, 2010.
The WiCell Research Institute (WiCell) and Advanced Cell Technology announced today an agreement, in principle, to collaborate to jointly distribute to U.S. scientists a range of new cell lines.
› Verified 3 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1366781700 PECOS PAC ID: 3779495858 Enrollment ID: O20130507000207 |
News Archive
A new study by researchers from Harvard T.H. Chan School of Public Health and colleagues describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.
TeamStaff, Inc. (Nasdaq: TSTF), a national provider of healthcare and administrative staffing services, today announced that on September 15, 2009, it received a notice from the Listing Qualifications Department of The Nasdaq Global Market (Nasdaq) stating that for the last 30 consecutive trading days, the Company's common stock has not maintained a minimum market value of publicly held shares of $5,000,000, as required by the continued listing requirements of the Nasdaq Global Market set forth in Listing Rule 5450(b)(1)(C) (the "Listing Rule").
For most patients, melanoma begins with a small, pigmented spot on their skin that they notice starts to change.
Ramius V&O Acquisition LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today announced that it has sent a letter to the Board of Directors of Cypress Bioscience, Inc. outlining its willingness to acquire all of Cypress' outstanding Common Stock in a negotiated transaction for $5.50 per share. The offer is conditioned upon Cypress commencing exclusive negotiations with Ramius no later than Friday, December 10, 2010 and entering into a definitive merger agreement by no later than Sunday, December 12, 2010.
The WiCell Research Institute (WiCell) and Advanced Cell Technology announced today an agreement, in principle, to collaborate to jointly distribute to U.S. scientists a range of new cell lines.
› Verified 3 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1497023188 PECOS PAC ID: 3779495858 Enrollment ID: O20131029000108 |
News Archive
A new study by researchers from Harvard T.H. Chan School of Public Health and colleagues describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.
TeamStaff, Inc. (Nasdaq: TSTF), a national provider of healthcare and administrative staffing services, today announced that on September 15, 2009, it received a notice from the Listing Qualifications Department of The Nasdaq Global Market (Nasdaq) stating that for the last 30 consecutive trading days, the Company's common stock has not maintained a minimum market value of publicly held shares of $5,000,000, as required by the continued listing requirements of the Nasdaq Global Market set forth in Listing Rule 5450(b)(1)(C) (the "Listing Rule").
For most patients, melanoma begins with a small, pigmented spot on their skin that they notice starts to change.
Ramius V&O Acquisition LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today announced that it has sent a letter to the Board of Directors of Cypress Bioscience, Inc. outlining its willingness to acquire all of Cypress' outstanding Common Stock in a negotiated transaction for $5.50 per share. The offer is conditioned upon Cypress commencing exclusive negotiations with Ramius no later than Friday, December 10, 2010 and entering into a definitive merger agreement by no later than Sunday, December 12, 2010.
The WiCell Research Institute (WiCell) and Advanced Cell Technology announced today an agreement, in principle, to collaborate to jointly distribute to U.S. scientists a range of new cell lines.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shirley Anne Vanmilder, MD 2101 East Jefferson Street, Kaiser Permanente, Ppqa, 6 West,, Rockville, MD 20852 Ph: (301) 816-6660 | Dr Shirley Anne Vanmilder, MD 1221 Mercantile Lane, Largo, MD 20774 Ph: (301) 618-5679 |
News Archive
A new study by researchers from Harvard T.H. Chan School of Public Health and colleagues describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.
TeamStaff, Inc. (Nasdaq: TSTF), a national provider of healthcare and administrative staffing services, today announced that on September 15, 2009, it received a notice from the Listing Qualifications Department of The Nasdaq Global Market (Nasdaq) stating that for the last 30 consecutive trading days, the Company's common stock has not maintained a minimum market value of publicly held shares of $5,000,000, as required by the continued listing requirements of the Nasdaq Global Market set forth in Listing Rule 5450(b)(1)(C) (the "Listing Rule").
For most patients, melanoma begins with a small, pigmented spot on their skin that they notice starts to change.
Ramius V&O Acquisition LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today announced that it has sent a letter to the Board of Directors of Cypress Bioscience, Inc. outlining its willingness to acquire all of Cypress' outstanding Common Stock in a negotiated transaction for $5.50 per share. The offer is conditioned upon Cypress commencing exclusive negotiations with Ramius no later than Friday, December 10, 2010 and entering into a definitive merger agreement by no later than Sunday, December 12, 2010.
The WiCell Research Institute (WiCell) and Advanced Cell Technology announced today an agreement, in principle, to collaborate to jointly distribute to U.S. scientists a range of new cell lines.
› Verified 3 days ago
Dr. Virgil Lee Graham, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1221 Mercantile Ln, Dept Of Obgyn, Largo, MD 20774 Phone: 301-618-5578 Fax: 301-618-5673 | |
Kieu Lashanya Smith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1221 Mercantile Ln, Largo, MD 20774 Phone: 301-618-5500 | |
Dr. Vera I Ibe, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1221 Mercantile Ln, Kaiser Permanente Largo Medical Center, Largo, MD 20774 Phone: 301-618-5500 Fax: 301-618-5673 | |
Dr. Teresita J Ferrer Estoye, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Lane, Largo, MD 20774 Phone: 301-618-5578 Fax: 301-618-5673 | |
Dr. Kimberly Shawn Moss, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Ln, Kaiser Permanente Largo Medical Center, Largo, MD 20774 Phone: 301-618-5500 | |
Dr. Helayne Marsha Silver, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1221 Mercantile Lane, Largo, MD 20774 Phone: 301-618-5578 Fax: 301-618-5673 |